Don't miss

Replay


LATEST SHOWS

MEDIAWATCH

Fans and players react online to Arsene Wegner's club departure

Read more

THE WORLD THIS WEEK

Syria alleged chemical attack: Gunfire delays deployment of weapons inspectors

Read more

FRANCE IN FOCUS

Cashing in on local French currencies

Read more

YOU ARE HERE

Life on the canals of northern France

Read more

INSIDE THE AMERICAS

What lies ahead for Cuba after the Castros?

Read more

#TECH 24

Discovering and harnessing the power of the sun

Read more

DOWN TO EARTH

Can France bid 'adieu' to popular weedkiller glyphosate?

Read more

#THE 51%

Harmful for your health: When gender bias affects medical diagnosis

Read more

REPORTERS

Africa’s donkeys slaughtered for Chinese ‘miracle elixir’

Read more

Sports

Tour de France winner Froome fails drugs test for asthma medication

© Jose Jordan, AFP | This file photo taken on September 10, 2017 shows Team Sky's British cyclist Chris Froome raising his trophy as he celebrates on the podium winning the 72nd edition of "La Vuelta" Tour of Spain cycling race.

Video by FRANCE 24

Text by NEWS WIRES

Latest update : 2017-12-13

Four-time Tour de France winner Chris Froome failed a drugs test for asthma medication during the Vuelta race in September, cycling's governing body UCI said on Wednesday.

The British Team Sky rider had twice the permitted level of legal asthma drug Salbutamol in his body.

The UCI has asked Froome to provide more information but has not suspended him.

Team Sky said the 32-year-old rider had suffered from asthma since childhood and had been affected by symptoms during the Vuelta a Espana, the Tour of Spain, which he went on to win.

But the team said he had taken no more than the allowable amount of Salbutamol.

"During the final week of the Vuelta, Chris experienced acute asthma symptoms. On the advice of the Team Sky doctor, he used an increased dosage of Salbutamol (still within the permissible doses) in the run-up to the 7 September urine test," Team Sky said.

The team said Froome had declared his use of the medication, adding: "The notification of the test finding does not mean that any rule has been broken."

Froome said the UCI was "absolutely right" to scrutinise the test results.

He said that during the race he had "followed the team doctor's advice to increase my Salbutamol dosage".

"As always, I took the greatest care to ensure that I did not use more than the permissible dose," he said.

"Together with the team, I will provide whatever information it requires," he added.

Froome was notified of the test on September 20, the day he finished third in the world time-trial championship in Bergen, Norway.

He has not competed since then, but has announced his intention to try to win the three big tours, in France, Spain and Italy, in 2018.

The test will raise new questions about British cycling following the scandal surrounding the only previous British Tour de France winner, Bradley Wiggins, over his use of so-called therapeutic use exemptions (TUEs).

It emerged that Wiggins received TUEs in order to take a corticosteroid before his three biggest races in 2011, 2012 and 2013, including his 2012 Tour de France win.

Wiggins and Sky have repeatedly denied any wrongdoing, saying the drug was prescribed to treat a longstanding pollen allergy.

(AFP)

Date created : 2017-12-13

  • CYCLING

    Chris Froome claims fourth Tour de France title

    Read more

  • France

    Boasson Hagen wins 19th stage of Tour de France after two 2nd-place finishes

    Read more

  • TOUR DE FRANCE

    Chris Froome: An unloved double champion

    Read more

COMMENT(S)